Cargando…

Serum Matrix Metalloproteinase‐9 and Cognitive Impairment After Acute Ischemic Stroke

BACKGROUND: The impact of serum matrix metalloproteinases‐9 (MMP‐9) on cognitive impairment after ischemic stroke is unclear. We aimed to investigate the association between serum MMP‐9 in the short‐term acute phase of ischemic stroke and cognitive impairment at 3 months. METHODS AND RESULTS: Our st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Chongke, Bu, Xiaoqing, Xu, Tan, Guo, Libing, Wang, Xuemei, Zhang, Jintao, Cui, Yong, Li, Dong, Zhang, Jianhui, Ju, Zhong, Chen, Chung‐Shiuan, Chen, Jing, Zhang, Yonghong, He, Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778973/ https://www.ncbi.nlm.nih.gov/pubmed/29306898 http://dx.doi.org/10.1161/JAHA.117.007776

Ejemplares similares

Serum tissue inhibitor of metalloproteinase‐1 and risk of cognitive impairment after acute ischaemic stroke
por: Ge, Jinzhuo, et al.
Publicado: (2020)

Soluble ST2 and risk of cognitive impairment after acute ischemic stroke: a prospective observational study
por: Zhu, Yinwei, et al.
Publicado: (2021)

Education Level and Long‐term Mortality, Recurrent Stroke, and Cardiovascular Events in Patients With Ischemic Stroke
por: Che, Bizhong, et al.
Publicado: (2020)

Involvement of Matrix Metalloproteinase 9 in Vertebral Arterial Dissection With Posterior Circulation Ischemic Stroke
por: Chen, Chun‐Yu, et al.
Publicado: (2020)

Sex-specific Association Between Uric Acid and Outcomes After Acute Ischemic Stroke: A Prospective Study from CATIS Trial
por: Chen, Li-Hua, et al.
Publicado: (2016)

The Role of Matrix Metalloproteinase Polymorphisms in Ischemic Stroke
por: Chang, Jason J., et al.
Publicado: (2016)

Meta-analysis of matrix metalloproteinase (MMP)-9 C1562T polymorphism and susceptibility to ischemic stroke in the Chinese population
por: Jiang, Yan, et al.
Publicado: (2020)

Immediate Antihypertensive Treatment for Patients With Acute Ischemic Stroke With or Without History of Hypertension: A Secondary Analysis of the CATIS Randomized Clinical Trial
por: Zhang, Rui, et al.
Publicado: (2019)

Angiopoietin‐like protein 4 and clinical outcomes in ischemic stroke patients
por: Zheng, Xiaowei, et al.
Publicado: (2021)

Plasma Human Cartilage Glycoprotein‐39 Is Associated With the Prognosis of Acute Ischemic Stroke
por: Xu, Tian, et al.
Publicado: (2022)

Correlation between the −1562C/T polymorphism in the matrix metalloproteinase-9 gene and hemorrhagic transformation of ischemic stroke
por: ZHANG, XIAOMAN, et al.
Publicado: (2015)

Association of DNA Methylation in Blood Pressure-Related Genes With Ischemic Stroke Risk and Prognosis
por: Zhang, Huan, et al.
Publicado: (2022)

Matrix metalloproteinase‐9 gene polymorphisms are associated with ischemic stroke severity and early neurologic deterioration in patients with atrial fibrillation
por: Yi, Xingyang, et al.
Publicado: (2019)

Serum dickkopf-3 is associated with death and vascular events after ischemic stroke: an observational study from CATIS
por: Zhu, Zhengbao, et al.
Publicado: (2020)

DNA Methylation of the Natriuretic Peptide System Genes and Ischemic Stroke: Gene-Based and Gene Set Analyses
por: Peng, Hao, et al.
Publicado: (2022)

Large‐Scale Targeted Sequencing Study of Ischemic Stroke in the Han Chinese Population
por: Shi, Mengyao, et al.
Publicado: (2022)

Occupational class differences in outcomes after ischemic stroke: a prospective observational study
por: Zhu, Yinwei, et al.
Publicado: (2021)

Soluble TREM2 is associated with death and cardiovascular events after acute ischemic stroke: an observational study from CATIS
por: Lu, Yaling, et al.
Publicado: (2022)

Role of Matrix Metalloproteinase-9 in Neonatal Hypoxic-Ischemic Encephalopathy
por: Salah, Mohab M., et al.
Publicado: (2019)

Prognostic significance of plasma SDF-1 in acute ischemic stroke patients with diabetes mellitus: the CATIS trial
por: You, Shoujiang, et al.
Publicado: (2023)

Sex‐Specific Relationship Between Serum Uric Acid and Risk of Stroke: A Dose‐Response Meta‐Analysis of Prospective Studies
por: Zhong, Chongke, et al.
Publicado: (2017)

Association between Increased Matrix Metalloproteinase-9 (MMP-9) Levels with Hyperglycaemia Incidence in Acute Ischemic Stroke Patients
por: Setyopranoto, Ismail, et al.
Publicado: (2018)

Matrix Metalloproteinase-9 (MMP-9) Gene Polymorphism in Stroke Patients
por: Buraczynska, Kinga, et al.
Publicado: (2015)

Variants in matrix metalloproteinase‐9 gene are associated with hemorrhagic transformation in acute ischemic stroke patients with atherothrombosis, small artery disease, and cardioembolic stroke
por: Yi, Xingyang, et al.
Publicado: (2019)

Predictive value of longitudinal changes of serum matrix metalloproteinase-9 and brain-derived neurotrophic factor in acute ischemic stroke
por: Li, Youjia, et al.
Publicado: (2022)

Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke
por: Lakhan, Shaheen E., et al.
Publicado: (2013)

Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke
por: Manso, Helena, et al.
Publicado: (2010)

Polymorphisms of the Matrix Metalloproteinase Genes are Associated with Acute Ischemic Stroke in Chinese Han Population
por: Li, Aifan, et al.
Publicado: (2023)

Corrigendum: Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke
por: Lakhan, Shaheen E., et al.
Publicado: (2018)

Bibliometric and visualization analysis of matrix metalloproteinases in ischemic stroke from 1992 to 2022
por: Gao, YiKun, et al.
Publicado: (2023)

Association of Matrix Metalloproteinase 9 and Cellular Fibronectin and Outcome in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Wang, Lu, et al.
Publicado: (2020)

Matrix Metalloproteinase-9 Gene Polymorphism and Its Methylation in Stroke Patients
por: CHOUDHARI, Omkar Kalidasrao, et al.
Publicado: (2021)

Regulation of Matrix Metalloproteinase-9 by Epigenetic Modifications and the Development of Diabetic Retinopathy
por: Zhong, Qing, et al.
Publicado: (2013)

Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations☆
por: Di, Fei, et al.
Publicado: (2012)

Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
por: Wei, Ting, et al.
Publicado: (2016)

Associations of B‐Type Natriuretic Peptide and Its Coding Gene Promoter Methylation With Functional Outcome of Acute Ischemic Stroke: A Mediation Analysis
por: Wang, Aili, et al.
Publicado: (2020)

Matrix metalloproteinase-2 gene polymorphisms are associated with ischemic stroke in a Hainan population
por: Niu, Fanglin, et al.
Publicado: (2018)

Matrix Metalloproteinase-9 as an Important Contributor to the Pathophysiology of Depression
por: Li, Hongmin, et al.
Publicado: (2022)

Association of systolic blood pressure after discharge and the risk of clinical outcomes in ischemic stroke patients with diabetes: a cohort study
por: Yang, Pinni, et al.
Publicado: (2023)

Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation
por: Zhang, Xiaoyan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fepgjk7v0srh9fu5p6qccvupnr